(Q68796572)
Statements
Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2 (English)
Ettinghausen SE
1 June 1986
scientific article published on 01 June 1986